These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
883 related articles for article (PubMed ID: 19308896)
1. Gene therapy for hemophilia: clinical trials and technical tribulations. Viiala NO; Larsen SR; Rasko JE Semin Thromb Hemost; 2009 Feb; 35(1):81-92. PubMed ID: 19308896 [TBL] [Abstract][Full Text] [Related]
2. Preclinical and clinical gene therapy for haemophilia. Chuah MK; Collen D; Vandendriessche T Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384 [TBL] [Abstract][Full Text] [Related]
3. Gene therapy strategies for hemophilia: benefits versus risks. Petrus I; Chuah M; VandenDriessche T J Gene Med; 2010 Oct; 12(10):797-809. PubMed ID: 20848668 [TBL] [Abstract][Full Text] [Related]
4. Gene transfer as an approach to treating hemophilia. High KA Semin Thromb Hemost; 2003 Feb; 29(1):107-20. PubMed ID: 12640573 [TBL] [Abstract][Full Text] [Related]
5. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia. High KA Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929 [TBL] [Abstract][Full Text] [Related]
8. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies. Van Damme A; Chuah MK; Collen D; VandenDriessche T Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences. Chuah M; Vandendriessche T Verh K Acad Geneeskd Belg; 2007; 69(5-6):315-34. PubMed ID: 18351211 [TBL] [Abstract][Full Text] [Related]
15. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9. Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610 [TBL] [Abstract][Full Text] [Related]
16. Gene therapy progress and prospects: gene therapy for the hemophilias. Walsh CE Gene Ther; 2003 Jun; 10(12):999-1003. PubMed ID: 12776156 [TBL] [Abstract][Full Text] [Related]
17. Factoring nonviral gene therapy into a cure for hemophilia A. Gabrovsky V; Calos MP Curr Opin Mol Ther; 2008 Oct; 10(5):464-70. PubMed ID: 18830922 [TBL] [Abstract][Full Text] [Related]
18. AAV vectors for hemophilia B gene therapy. Chao H; Walsh CE Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431 [TBL] [Abstract][Full Text] [Related]
19. Gene therapy for haemophilia "A" and "B": efficacy, safety and immune consequences. Chuah MK; Vandendriessche T Bull Mem Acad R Med Belg; 2007; 162(5-6):357-61. PubMed ID: 18405006 [TBL] [Abstract][Full Text] [Related]